Home | Welcome to Contract Pharma   
Last Updated Sunday, April 26 2015


Topics - APIs

Refine by Date:
From: To:
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 6, 2015
Opens a 1600L/1000L reactor stream, increases throughput for 400L reactors Read More »
Published April 6, 2015
Activities will be transitioned to other facilities, affecting approx. 62 positions Read More »
Published March 30, 2015
Will install a new Class 100,000 suite at its North East England facility Read More »
Laurus Synthesis Launches US Operations
Published March 20, 2015
Opens facility in Woburn, MA Read More »
Published March 11, 2015
New site will offer fully integrated formulation development services Read More »
Published March 11, 2015
High containment site is in Edinburgh, UK and part of the Macfarlan Smith division Read More »
Published March 4, 2015
Expands API development and manufacturing capabilities Read More »
Published February 27, 2015
Will offer production of API using microbial expression systems Read More »
Published February 17, 2015
To provide custom biomanufacturing for commercial production Read More »
Published February 3, 2015
Expands custom chemical and biochemical manufacturing portfolio Read More »
Pharmaceutical Fine Chemicals…Quo Vadit?
By Dr. Enrico T. Polastro , Arthur D. Little
Published January 29, 2015
Captive and merchant demand estimated at $80 billion and growing 4-5% per annum. Read More »
Published January 28, 2015
To manufacture Amotosalen API for Cerus Read More »
Published January 19, 2015
Will support development and manufacture of drug candidates for neurological disorders Read More »
Published December 15, 2014
Broadens access to key biotech hubs Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On